Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Pulmonary Hypertension

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 83 articles:
HTML format
Text format



Single Articles


    September 2017
  1. ZHANG H, Wang D, Li M, Plecita-Hlavata L, et al
    The Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension is Regulated through a MiR-124/PTBP1/PKM Axis.
    Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028069.
    PubMed     Text format     Abstract available


    July 2017
  2. LEISEGANG MS, Fork C, Josipovic I, Richter FM, et al
    Long Noncoding RNA MANTIS Facilitates Endothelial Angiogenic Function.
    Circulation. 2017;136:65-79.
    PubMed     Text format     Abstract available


    March 2017
  3. HWANGBO C, Lee HW, Kang H, Ju H, et al
    Modulation of Endothelial BMPR2 Activity by VEGFR3 in Pulmonary Arterial Hypertension.
    Circulation. 2017 Mar 29. pii: CIRCULATIONAHA.116.025390.
    PubMed     Text format     Abstract available


    February 2017
  4. CHEN J, Sysol JR, Singla S, Zhao S, et al
    Nicotinamide Phosphoribosyltransferase Promotes Pulmonary Vascular Remodeling and is a Therapeutic Target in Pulmonary Arterial Hypertension.
    Circulation. 2017 Feb 15. pii: CIRCULATIONAHA.116.024557.
    PubMed     Text format     Abstract available


    January 2017
  5. YANG P, Read C, Kuc RE, Buonincontri G, et al
    Elabela/Toddler is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of its Expression in Pulmonary Arterial Hypertension.
    Circulation. 2017 Jan 30. pii: CIRCULATIONAHA.116.023218.
    PubMed     Text format     Abstract available


    December 2016
  6. INAMI T, Kataoka M, Yanagisawa R, Ishiguro H, et al
    Long-Term Outcomes After Percutaneous Transluminal Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
    Circulation. 2016;134:2030-2032.
    PubMed     Text format    


    November 2016
  7. RHODES CJ, Ghataorhe P, Wharton J, Rue-Albrecht KC, et al
    Plasma Metabolomics Implicate Modified Transfer RNAs and Altered Bioenergetics in the Outcome of Pulmonary Arterial Hypertension.
    Circulation. 2016 Nov 21. pii: CIRCULATIONAHA.116.024602.
    PubMed     Text format     Abstract available


    August 2016
  8. VAN DER BRUGGEN CE, Happe CM, Goumans MJ, Bogaard HJ, et al
    Response by van der Bruggen et al to Letter Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
    Circulation. 2016;134:e117-8.
    PubMed     Text format    


  9. KATAOKA M, Satoh T, Fukuda K
    Letter by Kataoka et al Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
    Circulation. 2016;134:e115-6.
    PubMed     Text format    


  10. LI M, Riddle S, Zhang H, D'Alessandro A, et al
    Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Co-Repressor C-terminal Binding Protein-1.
    Circulation. 2016 Aug 25. pii: CIRCULATIONAHA.116.023171.
    PubMed     Text format     Abstract available


  11. LAI YC, Gladwin MT
    Response by Lai and Gladwin to Letter Regarding Article, "SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fractio
    Circulation. 2016;134:e79-80.
    PubMed     Text format    


  12. CARLSTROM M, Lundberg JO
    Letter by Carlstrom and Lundberg Regarding Article, "SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction".
    Circulation. 2016;134:e77-8.
    PubMed     Text format    


    July 2016
  13. SHAH SJ, Kitzman DW, Borlaug BA, van Heerebeek L, et al
    Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.
    Circulation. 2016;134:73-90.
    PubMed     Text format     Abstract available


    May 2016
  14. PRESTON IR, Roberts KE, Miller DP, Sen GP, et al
    Response to Letter Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)".
    Circulation. 2016;133:e662.
    PubMed     Text format    


  15. NIKPOUR M, Prior D, Celermajer D
    Letter by Nikpour et al Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)".
    Circulation. 2016;133:e661.
    PubMed     Text format    


  16. MARON BA
    Independence Day: Separating Right Ventricular Function from Pulmonary Arterial Hypertension in Systemic Sclerosis.
    Circulation. 2016 May 11. pii: CIRCULATIONAHA.116.023237.
    PubMed     Text format     Abstract available


  17. HSU S, Houston BA, Tampakakis E, Bacher AC, et al
    Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension.
    Circulation. 2016 May 11. pii: CIRCULATIONAHA.116.022082.
    PubMed     Text format     Abstract available


  18. CANNON JE, Su L, Kiely DG, Page K, et al
    Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort.
    Circulation. 2016;133:1761-71.
    PubMed     Text format     Abstract available


  19. STENMARK KR, Frid M, Perros F
    Endothelial-to-Mesenchymal Transition: An Evolving Paradigm and a Promising Therapeutic Target in PAH.
    Circulation. 2016;133:1734-7.
    PubMed     Text format    


    April 2016
  20. DAI Z, Li M, Wharton J, Zhu MM, et al
    PHD2 Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans through HIF-2alpha.
    Circulation. 2016 Apr 25. pii: CIRCULATIONAHA.116.021494.
    PubMed     Text format     Abstract available


  21. HOEPER MM
    Residual Pulmonary Hypertension After Pulmonary Endarterectomy: The Fog is Clearing.
    Circulation. 2016 Apr 6. pii: CIRCULATIONAHA.116.022595.
    PubMed     Text format     Abstract available


  22. HOPPER RK, Moonen JA, Diebold I, Cao A, et al
    In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and its Target Slug.
    Circulation. 2016 Apr 4. pii: CIRCULATIONAHA.115.020617.
    PubMed     Text format     Abstract available


    March 2016
  23. CHIU P, Irons M, van de Rijn M, Liang DH, et al
    Giant Pulmonary Artery Aneurysm in a Patient With Marfan Syndrome and Pulmonary Hypertension.
    Circulation. 2016;133:1218-21.
    PubMed     Text format    


  24. BRITTAIN EL, Talati M, Fessel JP, Zhu H, et al
    Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension.
    Circulation. 2016 Mar 22. pii: CIRCULATIONAHA.115.019351.
    PubMed     Text format     Abstract available


  25. VAN DER BRUGGEN CE, Happe CM, Dorfmuller P, Trip P, et al
    Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.
    Circulation. 2016 Mar 16. pii: CIRCULATIONAHA.115.020696.
    PubMed     Text format     Abstract available


    February 2016
  26. ANTIGNY F, Hautefort A, Meloche J, Belacel-Ouari M, et al
    Potassium-Channel Subfamily K-Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
    Circulation. 2016 Feb 24. pii: CIRCULATIONAHA.115.020951.
    PubMed     Text format     Abstract available


  27. HSU S, Kass DA
    Can Nitrite AMPk Up Sirt-ainty to Treat Heart Failure With Preserved Ejection Fraction?
    Circulation. 2016;133:692-4.
    PubMed     Text format    


  28. MARON BA, Hess E, Maddox TM, Opotowsky AR, et al
    Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the VA-CART Program.
    Circulation. 2016 Feb 12. pii: CIRCULATIONAHA.115.020207.
    PubMed     Text format     Abstract available


    January 2016
  29. DELCROIX M, Lang I, Pepke-Zaba J, Jansa P, et al
    Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Results From an International Prospective Registry.
    Circulation. 2016 Jan 29. pii: CIRCULATIONAHA.115.016522.
    PubMed     Text format     Abstract available


  30. LAI YC, Tabima DM, Dube JJ, Hughan KS, et al
    SIRT3-AMPK Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF).
    Circulation. 2016 Jan 26. pii: CIRCULATIONAHA.115.018935.
    PubMed     Text format     Abstract available


  31. CHEN X, Talati M, Fessel JP, Hemnes AR, et al
    Estrogen Metabolite 16alpha-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism.
    Circulation. 2016;133:82-97.
    PubMed     Text format     Abstract available


    December 2015
  32. WAXMAN AB, Farber HW
    Using Clinical Trial End Points to Risk Stratify Patients With Pulmonary Arterial Hypertension.
    Circulation. 2015;132:2152-61.
    PubMed     Text format    


    November 2015
  33. ABMAN SH, Hansmann G, Archer SL, Ivy DD, et al
    Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.
    Circulation. 2015 Nov 3. pii: CIR.0000000000000329.
    PubMed     Text format     Abstract available


    October 2015
  34. PRESTON IR, Roberts KE, Miller DP, Sen GP, et al
    Effect of Warfarin Treatment on Survival of Patients with Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL).
    Circulation. 2015 Oct 28. pii: CIRCULATIONAHA.115.018435.
    PubMed     Text format     Abstract available


    September 2015
  35. MOHAMMED SF, Forfia P, Redfield MM
    Response to Letter Regarding Article, "Right Ventricular Function in Heart Failure With Preserved Ejection Fraction: A Community-Based Study".
    Circulation. 2015;132:e161.
    PubMed     Text format    


  36. GUAZZI M
    Letter by Guazzi Regarding Article, "Right Ventricular Function in Heart Failure With Preserved Ejection Fraction: A Community-Based Study".
    Circulation. 2015;132:e160.
    PubMed     Text format    


  37. LAU EM, Montani D, Jais X, Sitbon O, et al
    Response to Letter Regarding Article, "Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension".
    Circulation. 2015;132:e154.
    PubMed     Text format    


  38. BABU AS, Padmakumar R, Maiya AG
    Letter by Babu et al Regarding Article, "Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension".
    Circulation. 2015;132:e153.
    PubMed     Text format    


  39. HANNA EB, Smart FW
    Letter by Hanna and Smart Regarding Article, "Clinical Diagnosis of Pulmonary Hypertension".
    Circulation. 2015;132:e133.
    PubMed     Text format    


    August 2015
  40. MACHUCA TN, de Perrot M
    Mechanical Support for the Failing Right Ventricle in Patients With Precapillary Pulmonary Hypertension.
    Circulation. 2015;132:526-36.
    PubMed     Text format    


    July 2015
  41. POTUS F, Ruffenach G, Dahou A, Thebault C, et al
    Downregulation of miR-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension.
    Circulation. 2015 Jul 10. pii: CIRCULATIONAHA.115.016382.
    PubMed     Text format     Abstract available


    June 2015
  42. MARON BA, Leopold JA
    Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension.
    Circulation. 2015;131:2079-91.
    PubMed     Text format    


    May 2015
  43. BHATT AB, Foster E, Kuehl K, Alpert J, et al
    Congenital heart disease in the older adult: a scientific statement from the American Heart Association.
    Circulation. 2015;131:1884-931.
    PubMed     Text format    


  44. RYAN JJ, Archer SL
    Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension.
    Circulation. 2015;131:1691-702.
    PubMed     Text format    


    April 2015
  45. RYAN JJ, Suksaranjit P, Hatton N, Bull DA, et al
    Eisenmenger syndrome with unrepaired patent ductus arteriosus.
    Circulation. 2015;131:e409-11.
    PubMed     Text format    


  46. BUTROUS G
    Human immunodeficiency virus-associated pulmonary arterial hypertension: considerations for pulmonary vascular diseases in the developing world.
    Circulation. 2015;131:1361-70.
    PubMed     Text format    


    March 2015
  47. ZALAWADIYA SK, Lindenfeld J, DiSalvo T
    Rapid diagnosis of cardiac tamponade using pulsatility index variability in a patient with a HeartWare ventricular assist device.
    Circulation. 2015;131:e387-8.
    PubMed     Text format    


  48. WEBBER SA, Hsu DT, Ivy DD, Kulik TJ, et al
    Task Force 7: Pediatric Cardiology Fellowship Training in Pulmonary Hypertension, Advanced Heart Failure, and Transplantation.
    Circulation. 2015 Mar 13. pii: CIR.0000000000000198.
    PubMed     Text format    


  49. VONK NOORDEGRAAF A, Haddad F, Bogaard HJ, Hassoun PM, et al
    Noninvasive imaging in the assessment of the cardiopulmonary vascular unit.
    Circulation. 2015;131:899-913.
    PubMed     Text format    


    February 2015
  50. REED DM, George PM, Mitchell JA
    Letter by reed et Al regarding article, "proteomic analysis implicates translationally controlled tumor protein as a novel mediator of occlusive vascular remodeling in pulmonary arterial hypertension".
    Circulation. 2015;131:e347.
    PubMed     Text format    


  51. WILKINS MR, Ghofrani HA, Weissmann N, Aldashev A, et al
    Pathophysiology and treatment of high-altitude pulmonary vascular disease.
    Circulation. 2015;131:582-90.
    PubMed     Text format    


  52. BARNES JW, Tian L, Heresi GA, Farver CF, et al
    O-GlcNAc Transferase Directs Cell Proliferation in Idiopathic Pulmonary Arterial Hypertension.
    Circulation. 2015 Feb 6. pii: CIRCULATIONAHA.114.013878.
    PubMed     Text format     Abstract available


    January 2015
  53. RANCHOUX B, Antigny F, Rucker-Martin C, Hautefort A, et al
    Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension.
    Circulation. 2015 Jan 15. pii: CIRCULATIONAHA.114.008750.
    PubMed     Text format     Abstract available


  54. OPOTOWSKY AR
    Clinical evaluation and management of pulmonary hypertension in the adult with congenital heart disease.
    Circulation. 2015;131:200-10.
    PubMed     Text format    


    December 2014
  55. MOURARET N, Houssaini A, Abid S, Quarck R, et al
    Role for Telomerase in Pulmonary Hypertension.
    Circulation. 2014 Dec 30. pii: CIRCULATIONAHA.114.013258.
    PubMed     Text format     Abstract available


  56. HUMBERT M, Lau EM, Montani D, Jais X, et al
    Advances in therapeutic interventions for patients with pulmonary arterial hypertension.
    Circulation. 2014;130:2189-208.
    PubMed     Text format    


  57. DUDZINSKI DM, Bhatt DL, Aragam JR, Maron BA, et al
    Explaining unexplained dyspnea: the ever "holesome" heart.
    Circulation. 2014;130:2057-66.
    PubMed     Text format    


    November 2014
  58. GOLDBERG JF, Mery CM, Griffiths PS, Parekh DR, et al
    Extracorporeal membrane oxygenation support in severe hypertrophic obstructive cardiomyopathy associated with persistent pulmonary hypertension in an infant of a diabetic mother.
    Circulation. 2014;130:1923-5.
    PubMed     Text format    


  59. CHATTERJEE N, Steiner J, Lewis GD
    It's Time to Look at Heart Failure with Preserved Ejection Fraction from the Right Side.
    Circulation. 2014 Nov 12. pii: CIRCULATIONAHA.114.013536.
    PubMed     Text format     Abstract available


  60. MOHAMMED SF, Hussain I, Abou Ezzeddine OF, Takahama H, et al
    Right Ventricular Function in Heart Failure with Preserved Ejection Fraction: A Community Based Study.
    Circulation. 2014 Nov 12. pii: CIRCULATIONAHA.113.008461.
    PubMed     Text format     Abstract available


  61. RICH JD, Rich S
    Clinical diagnosis of pulmonary hypertension.
    Circulation. 2014;130:1820-30.
    PubMed     Text format    


  62. LEOPOLD JA, Maron BA
    New thematic series: recent advances in pulmonary hypertension.
    Circulation. 2014;130:1771.
    PubMed     Text format    


    October 2014
  63. HEMNES AR, Trammell AW, Archer SL, Rich S, et al
    A Peripheral Blood Signature of Vasodilator-Responsive Pulmonary Arterial Hypertension.
    Circulation. 2014 Oct 31. pii: CIRCULATIONAHA.114.013317.
    PubMed     Text format     Abstract available


  64. MAEMURA S, Ishizuka M, Nakata R, Motozawa Y, et al
    Pulmonary hypertension caused by persistent anomalous vertical vein bridging the left subclavian vein and left atrium with hypertrophic cardiomyopathy.
    Circulation. 2014;130:e153-6.
    PubMed     Text format    


  65. KIM J, Hwangbo C, Hu X, Kang Y, et al
    Restoration of Impaired Endothelial MEF2 Function Rescues Pulmonary Arterial Hypertension.
    Circulation. 2014 Oct 21. pii: CIRCULATIONAHA.114.013339.
    PubMed     Text format     Abstract available


    September 2014
  66. OLSSON KM, Delcroix M, Ghofrani HA, Tiede H, et al
    Response to Letters Regarding Article, "Anticoagulation and Survival in Pulmonary Arterial Hypertension: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)".
    Circulation. 2014;130:e110-2.
    PubMed     Text format    


  67. OGAWA A, Matsubara H
    Letter by Ogawa and Matsubara Regarding Article, "Anticoagulation and Survival in Pulmonary Arterial Hypertension: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)".
    Circulation. 2014;130:e109.
    PubMed     Text format    


  68. BERTOLETTI L, Mismetti P, Decousus H
    Letter by Bertoletti et al Regarding Article, "Anticoagulation and Survival in Pulmonary Arterial Hypertension: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)".
    Circulation. 2014;130:e108.
    PubMed     Text format    


  69. SUISSA S, Galie N
    Letter by Suissa and Galie Regarding Article, "Anticoagulation and Survival in Pulmonary Arterial Hypertension: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)".
    Circulation. 2014;130:e107.
    PubMed     Text format    


    August 2014
  70. LANG IM, Madani M
    Update on chronic thromboembolic pulmonary hypertension.
    Circulation. 2014;130:508-18.
    PubMed     Text format    


    July 2014
  71. SHIMOKAWAHARA H, Ijuuin S, Sonoda K, Sai E, et al
    The value of lung perfused blood volume computed tomography in selecting the target lesions for the effective treatment of chronic thromboembolic pulmonary hypertension.
    Circulation. 2014;130:448-9.
    PubMed     Text format    


  72. AMSELLEM V, Lipskaia L, Abid S, Poupel L, et al
    CCR5 as a Treatment Target in Pulmonary Arterial Hypertension.
    Circulation. 2014 Jul 3. pii: CIRCULATIONAHA.114.010757.
    PubMed     Text format     Abstract available


    June 2014
  73. SHARMA S, Umar S, Potus F, Iorga A, et al
    ApoA-I Mimetic Peptide 4F Rescues Pulmonary Hypertension by Inducing MicroRNA-193-3p.
    Circulation. 2014 Jun 24. pii: CIRCULATIONAHA.114.007405.
    PubMed     Text format     Abstract available


  74. VENTETUOLO CE, Gabler NB, Fritz JS, Smith KA, et al
    Are Hemodynamics Surrogate Endpoints in Pulmonary Arterial Hypertension?
    Circulation. 2014 Jun 20. pii: CIRCULATIONAHA.114.009690.
    PubMed     Text format     Abstract available


  75. BUBB KJ, Trinder SL, Baliga RS, Patel J, et al
    Inhibition of Phosphodiesterase 2 Augments cGMP and cAMP Signaling to Ameliorate Pulmonary Hypertension.
    Circulation. 2014 Jun 4. pii: CIRCULATIONAHA.114.009751.
    PubMed     Text format     Abstract available


    April 2014
  76. SCHAFFER JM, Singh SK, Joyce DL, Reitz BA, et al
    Response to letter regarding article, "transplantation for idiopathic pulmonary arterial hypertension: improvement in the lung allocation score era".
    Circulation. 2014;129:e458.
    PubMed     Text format    


  77. EBERLEIN M, Reed RM
    Letter by eberlein and reed regarding article, "transplantation for idiopathic pulmonary arterial hypertension: improvement in the lung allocation score era".
    Circulation. 2014;129:e457.
    PubMed     Text format    


  78. FISHER EA, Miano JM
    Don't judge books by their covers: vascular smooth muscle cells in arterial pathologies.
    Circulation. 2014;129:1545-7.
    PubMed     Text format    


  79. WEISEL FC, Kloepping C, Pichl A, Sydykov A, et al
    Impact of S-adenosylmethionine decarboxylase 1 on pulmonary vascular remodeling.
    Circulation. 2014;129:1510-23.
    PubMed     Text format     Abstract available


    March 2014
  80. HUERTAS A, Perros F, Tu L, Cohen-Kaminsky S, et al
    Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay.
    Circulation. 2014;129:1332-40.
    PubMed     Text format    


  81. LAVOIE JR, Ormiston M, Perez-Iratxeta C, Courtman DW, et al
    Proteomic Analysis Implicates Translationally Controlled Tumor Protein as a Novel Mediator of Occlusive Vascular Remodeling in Pulmonary Arterial Hypertension.
    Circulation. 2014.
    PubMed     Text format     Abstract available


  82. BARST RJ, Beghetti M, Pulido T, Layton G, et al
    STARTS-2: Long-Term Survival With Oral Sildenafil Monotherapy in Treatment-Naive Pediatric Pulmonary Arterial Hypertension.
    Circulation. 2014.
    PubMed     Text format     Abstract available


    February 2014
  83. WOJCIAK-STOTHARD B, Abdul-Salam VB, Lao KH, Tsang H, et al
    Aberrant Chloride Intracellular Channel 4 Expression Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension.
    Circulation. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: